Effectiveness of Laserpuncture and Antiemetic on RINVR Scores in Adolescent Undergoing Chemotherapy

Sponsor
Indonesia University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06121414
Collaborator
(none)
58
2
30

Study Details

Study Description

Brief Summary

Chemotherapy is a common treatment for treating cancer. Chemotherapy induced nausea and vomiting (CINV) is nausea and vomiting that occurs after chemotherapy. Complete protection of standard antiemetic drugs against CINV symptoms in children and adolescents receiving moderately and strongly emetogenic chemotherapy drugs was less than 50%.

The side effects of chemotherapy in the form of CINV are so unpleasant that chemotherapy causes extreme anxiety and stress. The psychological characteristics of adolescents who have a greater perception of the changes that occur cause more frequent anxiety which can increase the risk of CINV.

Acupuncture with laserpuncture modality is a non-pharmacological therapy that has a good effect on CINV symptoms in adolescents. This research was conducted for the first time in Brazil in 2019, while in Indonesia there has never been any research on this matter. So it is hoped that this research will be the first research in Indonesia to prove that the effect of laserpuncture plays a role in CINV symptoms in adolescents and can be an additional treatment in standard therapy for CINV problems in adolescents.

Condition or Disease Intervention/Treatment Phase
  • Device: laserpuncture
  • Device: Sham Laserpuncture
N/A

Detailed Description

This is a clinical trial study to evaluate and compare the effects of laserpuncture and sham laserpuncture as a therapy for Chemotherapy induced nausea and vomiting (CINV) . The subjects are 58 males/female and will be randomly assigned to 2 groups: (1) laserpunctur and (2) Sham laserpuncture. The outcome will be assessed before treatment (baseline), in chemotherapy procedure and 3 days after chemotherapy. Patients and the outcome assessors will be blinded to the group allocation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
58 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effectiveness of Combined Laserpuncture With Antiemetic Therapy on the Rhodes Index of Nausea, Vomiting and Reatching (RINVR) Scores in Adolescent Cancer Patients Undergoing Chemotherapy
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Laserpuncture

Laserpuncture using continous wave, 2 Joule in on condition

Device: laserpuncture
laserpuncture use continous wave,dose 2 Joule, 785nm, 50mw

Sham Comparator: Sham Laserpuncture

Sham laser using laserpuncture in off condition

Device: Sham Laserpuncture
Sham laser using laserpuncture in off condition

Outcome Measures

Primary Outcome Measures

  1. Rhodes Index nausea, vomiting and Reatching Score (RINVR) [before chemotherapy, in chemotherapy procedure, 3 days after chemotherapy]

    Score for measuring nausea, vomiting and reatching after chemotherapy. minimum score is 0 and maximum score is 32

Other Outcome Measures

  1. Screen for Child Anxiety Related Disorders (SCARED) [before Chemotherapy, 3 days after chemotherapy]

    Score for measuring anxiety for Child. score 25 or more is anxiety. minimum score is 0 and maximum score is 82

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Adolescent cancer patients aged 10 - 18 years

  2. Patients undergoing chemotherapy with moderate and/or strong emetogenic chemotherapy drugs

  3. Patients with CINV and/or at risk of CINV

  4. Willing to take part in research until completion

  5. The patient has not received acupuncture therapy in the last 1 week

Exclusion Criteria:
  1. Patients with cancerous lesions or ulcers at the location of the acupuncture points to be selected

  2. Patients with digestive tract organ malignancies with complaints of nausea and vomiting before chemotherapy

  3. Patients with unstable hemodynamic conditions

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Indonesia University

Investigators

  • Principal Investigator: KEPK FKUI KR RSCM, The Ethics Committee of the Faculty Of Medicine, University of Indonesia- Cipto Mangunkusumo Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ramadia Yunita, doctor, Indonesia University
ClinicalTrials.gov Identifier:
NCT06121414
Other Study ID Numbers:
  • 23061053
First Posted:
Nov 8, 2023
Last Update Posted:
Nov 14, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 14, 2023